Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer

被引:0
|
作者
I. V. Balalaeva
L. V. Krylova
M. A. Karpova
A. A. Shulga
E. V. Konovalova
E. L. Guryev
S. M. Deyev
机构
[1] Lobachevsky State University of Nizhny Novgorod,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Sechenov First Moscow State Medical University,undefined
来源
关键词
targeted therapy; recombinant anticancer toxin; DARPin-LoPE; photodynamic therapy; photodithazine; breast cancer; HER2 receptor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:330 / 333
页数:3
相关论文
共 50 条
  • [41] EFFICACY OF HER2-TARGETED ANTIBODY THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS
    Hulsbergen, Alexander
    Broekman, Marike
    Smith, Timothy
    Aizer, Ayal A.
    Iorgulescu, Bryan
    NEURO-ONCOLOGY, 2020, 22 : 131 - 131
  • [42] Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer
    Gupta, Anshul
    Gogia, Ajay
    Deo, S. V. S.
    Sharma, D. N.
    Mathur, Sandip
    Sagiraju, Hari Krishna Raju
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [43] Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer
    Steadman, Jessica A.
    Hieken, Tina J.
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 130 (03) : 366 - 370
  • [44] Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
    Du, Jiaqun
    Liu, Xiaobang
    Sun, Junpeng
    Wu, Qian
    Hu, Yu
    Shi, Huan
    Zheng, Li
    Liu, Ying
    Wu, Chao
    Gao, Yu
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [45] Recent advances in novel targeted therapies for HER2-positive breast cancer
    Murphy, Conleth G.
    Morris, Patrick G.
    ANTI-CANCER DRUGS, 2012, 23 (08) : 765 - 776
  • [46] Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
    Simmons, Christine
    Rayson, Daniel
    Joy, Anil Abraham
    Henning, Jan-Willem
    Lemieux, Julie
    McArthur, Heather
    Card, Paul B.
    Dent, Rebecca
    Brezden-Masley, Christine
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [47] Targeted therapeutic options and future perspectives for HER2-positive breast cancer
    Wang, Jiani
    Xu, Binghe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [48] Targeted therapeutic options and future perspectives for HER2-positive breast cancer
    Jiani Wang
    Binghe Xu
    Signal Transduction and Targeted Therapy, 4
  • [49] Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond
    Zardavas, Dimitrios
    Pugliano, Lina
    Ades, Felipe
    Bozovic-Spasojevic, Ivana
    Capelan, Marta
    de Azambuja, Evandro
    BREAST CANCER MANAGEMENT, 2012, 1 (03) : 217 - 233
  • [50] Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
    Ferrando-Diez, Angelica
    Felip, Eudald
    Pous, Anna
    Bergamino Sirven, Milana
    Margeli, Mireia
    CANCERS, 2022, 14 (14)